MNK-EIF4E

N/A

Report date: 2025/07/28 16:54:13

NME

Base Information

Drug NameMNK-EIF4E

Drug Alias NameMNK-EIF4E

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionMAP kinase-interacting serine/threonine-protein kinase MNK1 inhibitorsMAP kinase-interacting serine/threonine-protein kinase 2 inhibitors

TargetsMAP kinase-interacting serine/threonine-protein kinase 2MAP kinase-interacting serine/threonine-protein kinase MNK1

Therapy Area/IndicationsAcute Pain

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator Companies4E Therapeutics Inc

China Registration ClassN/A

Develop Information

Active Companies4E Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsAcute Pain

Inactive IndicationsN/A

Other Information

ATC CodeN/A